Details of the Probe-central Interaction Altas
General Information of Experiment
| Probe Name | CR-1 | Probe Info | ||||
|---|---|---|---|---|---|---|
| Probe concentration | 1 uM | |||||
| Criteria | Quantification: Probe vs (Probe+Competitor) | |||||
| Quantitative Method |
SILAC
|
|||||
| Competitor Name | Crenolanib | Competitor Info | ||||
| Competitor Concentration | 10 uM | |||||
| In Vivo Experiment Model | Model Type |
|
Living cell | |||
| Derived Tissue |
|
Peripheral blood | ||||
| Disease Model | Acute monocytic leukemia [ICD-11:2A60] | |||||
| Model Name | Human acute monocytic leukemia cells (MV4-11) | |||||
Interaction Altas of This Experiment [1]
Enzyme
| Target ID | Target Name | Binding Ratio | ||||
|---|---|---|---|---|---|---|
| LDTP02783 | Ubiquitin carboxyl-terminal hydrolase isozyme L3 (UCHL3) | 3.7 | ||||
Other
| Target ID | Target Name | Binding Ratio | ||||
|---|---|---|---|---|---|---|
| LDTP14014 | Chromatin target of PRMT1 protein (CHTOP) | 3.1 | ||||
| LDTP04931 | 10 kDa heat shock protein, mitochondrial (HSPE1) | 2.9 | ||||
| LDTP11179 | LIM domain-containing protein 2 (LIMD2) | 2.8 | ||||
| LDTP15701 | EF-hand domain-containing protein D2 (EFHD2) | 2.5 | ||||
